Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089903 · ClinicalTrials.gov registry record · NA
Breast Cancer Outreach Among Primary Care Patients
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 24,680
- Enrollment target
NCT05089903: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT05089903 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 24,680 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1659% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05089903, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 24,680 participants
- Enrollment target
Study Summary
This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among eligible patients, including ordering mammograms in bulk prior to outreach, sending personalized text reminders, and endorsing of the communication by the primary care provider.
Primary Outcome
Percent of patients that complete a mammogram
Interventions
- BEHAVIORAL Texting
- BEHAVIORAL Bulk Order
- BEHAVIORAL Clinician Endorsement
- BEHAVIORAL No Bulk Order
- BEHAVIORAL Standard Endorsement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,680 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
What the finished NCT05089903 record still lists
NCT05089903 is an interventional study that assigns participants to a tested intervention. Its 24,680 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1659% higher).
The record links to 0 conditions, and to 5 interventions - of which Texting is the first listed.
NCT05089903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05089903 about?
NCT05089903 is a clinical study titled "Breast Cancer Outreach Among Primary Care Patients". This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among e...
What is the current status of trial NCT05089903?
This trial is currently completed. It is a NA study. The enrollment target is 24,680 participants. The study started on 2021-10-25. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT05089903?
The interventions under investigation include: Texting (BEHAVIORAL), Bulk Order (BEHAVIORAL), Clinician Endorsement (BEHAVIORAL), No Bulk Order (BEHAVIORAL), Standard Endorsement (BEHAVIORAL).
Who is sponsoring clinical trial NCT05089903?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05089903's enrollment target sits among peer trials
24,680 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
- NCT06773897 · 25,000 participants
Rutgers University Study of the Genetics of Breast Cancer.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI